Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Drugs Under Experimental and Clinical Research|January 1, 1989
Comparative effects of three beta-lactam antibiotics on anti-PC direct plaque-forming cellsI Corrales, A Suarez, R Sanz, et al.
Therapeutic Advances in Hematology|June 24, 2022
The potential of pirtobrutinib in multiple B-cell malignanciesJeffrey L Jensen, Anthony R Mato, Camila Pena, et al.
British Journal of Haematology|June 10, 2026
Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemiaJohanne U Hermansen, Yanping Yin, Geir E Tjønnfjord, et al.
American Journal of Hematology|September 20, 2022
Approach to a patient with "double refractory" chronic lymphocytic leukemia: "Double, double toil and trouble" (Shakespeare)Julia H Aronson, Sigrid S Skånland, Lindsey E Roeker, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Virtually all methicillin-resistant Staphylococcus aureus (MRSA) infections in the largest Portuguese teaching hospital are caused by two internationally spread multiresistant strains: the 'Iberian' and the 'Brazilian' clones of MRSAD. Oliveira, I. Santos-Sanches, R. Mato, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 17, 2004
Clonal types and multidrug resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) recovered in Italy during the 1990sR Mato, F Campanile, S Stefani, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 3, 1998
Spread of the multiresistant Iberian clone of methicillin-resistant Staphylococcus aureus (MRSA) to Italy and ScotlandR Mato, I Santos Sanches, M Venditti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2025
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic LeukemiaYanping Yin, Haifeng Xu, Liye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2020
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte)Elise A Chong, Lindsey E Roeker, Mazyar Shadman, et al.
Leukemia & Lymphoma|October 3, 2018
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United StatesRavi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.
Pageof 12